Pharmafile Logo

News and Press Releases

Anocca Raises SEK 440 Million to Advance Clinical Trial Targeting Pancreatic Cancer

Financing supports execution of early-stage clinical trials for Anocca’s lead programme VIDAR-1, powered by the Company’s leading-edge R&D platform, to target pancreatic cancer VIDAR-1 is the first non-viral gene-edited TCR-T...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: August 18, 2025

Anocca
info@anocca.com
Forskargatan 20C 151 36 Södertälje, Sweden

Owlstone Medical Announces $27 Million USD First Close in Series E Financing Round

Led by Ventura Capital and joined by other investors including Aviva Ventures, the Gates Foundation and Horizons Ventures Funding will be used to accelerate commercialization and further clinical trials of...

Category: Drug Discovery
Posted: January 17, 2025

Owlstone Medical
breathbiopsy@owlstone.co.uk
Owlstone Ltd, 127 Cambridge Science Park, Milton Road, Cambridge, CB4 0GD, UK

ILC Therapeutics completes £2.5m financing and bolsters C-suite

Owain Millington appointed CEO, Julie Bailey appointed CFO and Dawn Firmin appointed COO Financing to support pre-clinical development of ILCT’s two lead assets 11 September 2024 -- Glasgow, UK --...

Category:
Posted: September 13, 2024

ILC Therapeutics
ILCTherapeutics@walbrookpr.com
75 King William Street London EC4N 7BE

KADANS SCIENCE PARTNER WELCOMES NEW TENANT MYRICX BIO TO LONDON INNOVATION CENTRE AT CANARY WHARF

Myricx Bio joins Kadans’ pioneering innovation centre in Canary Wharf, providing the facilities for its future expansion and pipeline progression, following a recent £90m Series A financing 12 September 2024:...

Category: BioManufacturing, Biotechnology
Posted: September 12, 2024

Kadans Science Partner
info@kadans.com
Rijksweg 5 5076 PB Haaren The Netherlands

Asceneuron Secures $100m Series C Financing to Advance Groundbreaking Therapeutics in Neurodegenerative Diseases

Financing led by Novo Holdings, including new investment from EQT Life Sciences – LSP Dementia Fund, OrbiMed and SR One with participation from existing investors M Ventures, Sofinnova Partners, GSK...

Category: Biotechnology, Clinical Trials, Other
Posted: July 16, 2024

Asceneuron SA
asce-contact@asceneuron.com
Asceneuron SA, EPFL Innovation Park, Bâtiment B, CH-1015 Lausanne, Switzerland

Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development

£90m ($114m) series A co-led by new leading life science investors Novo Holdings and Abingworth Additional new investors British Patient Capital, Cancer Research Horizons and Lilly participated alongside founding investors...

Category: BioManufacturing, Clinical Trials, Other
Posted: July 8, 2024

Myricx
info@myricxbio.com
Myricx Bio Gridiron Building, 1 Pancras Square, King’s Cross, London, N1C 4AG

Primrose Bio Announces Investment from 1315 Capital to Advance Manufacturing Solutions for Next-Generation Therapeutics

June 17 2024 - California, US – Primrose Bio, Inc. (“Primrose,” the “company”), a company focused on developing and licensing its manufacturing technologies for nucleic acids and proteins used in...

Category: Biotechnology, Drug Delivery, Other
Posted: June 18, 2024

Primrose Bio
media@primrosebio.com
Primrose Bio, 10790 Roselle Street, San Diego, CA 92121 United States

Oxford Drug Design and CRUK Scotland Institute awarded MRC grant funding to advance novel cancer therapeutics discovery

Collaboration to use genetically engineered mouse models to validate a new approach to cancer therapy 4 June 2024 - United Kingdom - The CRUK (Cancer Research UK) Scotland Institute and Oxford...

Category: Drug Discovery
Posted: June 10, 2024

Oxford Drug Design
contactus@oxforddrugdesign.com
Oxford Drug Design Lt,d Oxford Centre for Innovation, New Road, Oxford, OX1 1BY, UK

PlaqueTec closes $8m equity financing

The financing was led by Lord Moynihan of Chelsea alongside The Future Fund, with support from existing investors Funding will support ongoing BIOPATTERN trial and build BIOCARTA database to transform...

Category: Biotechnology, Other, Pharmaceutical
Posted: April 30, 2024

PlaqueTec
info@plaquetec.com
Maia Building (B270) Babraham Research Campus Cambridge CB22 3AT